Target intelligence / Profile preview

RNA polymerase II, I and III subunit L (POLR2L)

Target
POLR2L
Molecular classification
Enzyme, Transcription factor (as a core component of RNA polymerase complexes)
01

Overview

RNA polymerase II, I and III subunit L (POLR2L) is a highly conserved protein subunit shared by the three major nuclear DNA-dependent RNA polymerases (I, II, and III), which catalyze the transcription of DNA into various classes of RNA, including messenger RNA (mRNA), ribosomal RNA (rRNA), and several small non-coding RNAs. The POLR2L protein is characterized by four conserved cysteines forming an atypical zinc-binding domain. As a core component, it plays a structural and functional role in the assembly, stability, and activity of the multi-subunit RNA polymerase complexes essential for gene expression in all eukaryotic cells. Mutations in POLR2L have been associated with rare hereditary diseases such as Cockayne syndrome and Hyperparathyroidism 2 with jaw tumors[1][2][7][9]. No drugs are known to specifically target this subunit due to its fundamental and ubiquitous role in cell survival.

Other names
DNA-directed RNA polymerases I, II, and III subunit RPABC5DNA-directed RNA polymerase III subunit LRNA polymerase II 7.6 kDa subunitRPB10RPB10betaRPB7.6hRPB7.6hsRPB10bRPABC5RBP10polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDapolymerase (RNA) II subunit LHRPB7.6HSRPB10B
02

Biological functions

DNA transcriptionmRNA synthesissynthesis of ribosomal RNA and small RNAs (e.g., 5S rRNA, tRNAs)non-coding RNA synthesis
03

Disease associations

Cancer (potential relevance via transcriptional dysregulation)Cockayne syndromeHyperparathyroidism 2 with jaw tumors
04

Safety considerations

Essential component of general transcription machinery—systemic inhibition likely to result in high toxicity due to loss of global RNA synthesis

Beyond the preview

Go deeper on RNA polymerase II, I and III subunit L (POLR2L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase II, I and III subunit L (POLR2L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call